What amount sold does SPECTRASCIENCE INC report in Form D filings?

The latest linked filings report $5.9M sold across 7 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was SPECTRASCIENCE INC's most recent SEC filing?

SPECTRASCIENCE INC's most recent Form D filing was on 2014-01-09.

How many investors does SPECTRASCIENCE INC have?

The most recent Form D filing lists 4 investor(s).

What type of securities does SPECTRASCIENCE INC offer?

SPECTRASCIENCE INC's SEC Form D filings indicate debt offerings.

SPECTRASCIENCE INC

CIK: 0000727672·Other Health Care·San Diego, CA·Corporation

Reported Sold

$5,893,231

Total Filings

Identified Offerings

Last Filed

Jan 9, 2014

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Other Health Care industry

SEC EDGAR

Offering filing timeline

Jan 9, 2014Form D/A — Amendment

Reported sold: $1,250,000 · Target: $2,500,000

Rule 506(b)·4 investors

Changed: Reported amount sold, Offering target, Reported investors, Finders fees

Sep 25, 2013Form D — New notice

Reported sold: $500,000 · Target: $1,000,000

Rule 506(b)·2 investors

Jan 30, 2013Form D — New notice

Reported sold: $0 · Target: $1,000,000

Rule 506·0 investors

Sep 6, 2012Form D — New notice

Reported sold: $260,000 · Target: $1,500,000

Rule 506·7 investors

Mar 19, 2012Form D — New notice

Reported sold: $0 · Target: $500,000

Rule 506·0 investors

Jan 27, 2012Form D — New notice

Reported sold: $300,000 · Target: $1,800,000

Rule 506·4 investors

Aug 3, 2010Form D — New notice

Reported sold: $3,153,231 · Target: $5,000,000

Rule 506·33 investors

Aug 3, 2009Form D — New notice

Reported sold: $930,000 · Target: $5,000,000

Rule 506·8 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

$1,079,388

Amendment Rate

13%

Latest reported sold across 7 identified offerings

$5,893,231

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

F. Duwaine Townsen

Related Person

Appears on 5 filings

Mark McWilliams

Related Person

Appears on 5 filings

Michael P. Oliver

Related Person

Appears on 4 filings

Sheldon L. Miller

Related Person

Appears on 4 filings

Chester E. Sievert, Jr.

Related Person

Appears on 4 filings

Stan Pappelbaum

Related Person

Appears on 2 filings

Stanley J. Pappelbaum

Related Person

Appears on 2 filings

James Dorst

Related Person

Appears on 2 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Jan 9, 2014	Amendment	$2,500,000	$1,250,000	4
Sep 25, 2013	New	$1,000,000	$500,000	2
Jan 30, 2013	New	$1,000,000	$0	0
Sep 6, 2012	New	$1,500,000	$260,000	7
Mar 19, 2012	New	$500,000	$0	0
Jan 27, 2012	New	$1,800,000	$300,000	4
Aug 3, 2010	New	$5,000,000	$3,153,231	33
Aug 3, 2009	New	$5,000,000	$930,000	8

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

RCE Technologies, Inc.

Other Health Care

Offering target: $3,000,000

Filed Oct 23, 2026